- ISIN
- US67074Y1055
- Sector
- Financial Services
- Industry
- Asset Management
Highlights
- Market Cap
- $350.41M
- Enterprise Value
- $526.68M
- EPS (TTM)
- $2.72
- PE Ratio
- 4.69
- Total Revenue (TTM)
- $85.35M
- Gross Profit (TTM)
- $56.69M
- EBITDA (TTM)
- $92.52M
- Year Range
- $11.67 - $14.27
- ROA (TTM)
- 13.73%
- ROE (TTM)
- 20.33%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
JRI Performance Chart
Nuveen Real Asset Income and Growth Fund (JRI) is down 0.6% since the beginning of the year. At $13 per share, JRI is trading 10.5% below its 52-week high of $14. Investors who bought $1,000 worth of JRI shares 5 years ago would now be looking at an investment worth $1,345.
Loading charts...
Returns By Period
Nuveen Real Asset Income and Growth Fund (JRI) has returned -0.61% so far this year and 11.80% over the past 12 months. Over the last ten years, JRI has returned 7.17% per year, falling short of the S&P 500 Index benchmark, which averaged 13.75% annually.
Nuveen Real Asset Income and Growth Fund
- 1D
- 0.87%
- 1M
- -0.22%
- YTD
- -0.61%
- 6M
- -0.29%
- 1Y
- 11.80%
- 3Y*
- 17.04%
- 5Y*
- 6.10%
- 10Y*
- 7.17%
Benchmark (S&P 500 Index)
- 1D
- 0.13%
- 1M
- 5.68%
- YTD
- 11.16%
- 6M
- 11.10%
- 1Y
- 27.46%
- 3Y*
- 21.12%
- 5Y*
- 12.66%
- 10Y*
- 13.75%
JRI Monthly Returns History
Based on dividend-adjusted daily data since Apr 27, 2012, JRI's average daily return is +0.04%, while the average monthly return is +0.77%. At this rate, an investment would double in approximately 7.5 years.
Historically, 64% of months were positive and 36% were negative. The best month was Apr 2020 with a return of +15.4%, while the worst month was Mar 2020 at -38.7%. The longest winning streak lasted 13 consecutive months, and the longest losing streak was 3 months.
On a daily basis, JRI closed higher 53% of trading days. The best single day was Mar 25, 2020 with a return of +14.0%, while the worst single day was Mar 18, 2020 at -26.1%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -2.95% | 3.37% | -6.51% | 6.71% | 0.48% | -1.16% | -0.61% | ||||||
| 2025 | 4.44% | 5.00% | 0.42% | 0.88% | 1.29% | 5.40% | -1.76% | 4.62% | 5.77% | -1.52% | 0.25% | -0.41% | 26.76% |
| 2024 | 0.76% | -1.44% | 4.57% | -3.71% | 3.00% | 6.45% | 4.57% | 4.35% | 6.23% | -3.34% | 5.11% | -9.97% | 16.27% |
| 2023 | 11.03% | -5.57% | -2.07% | 0.83% | -5.06% | 3.96% | 2.61% | -3.22% | -4.16% | -5.14% | 11.73% | 6.80% | 10.08% |
| 2022 | -4.14% | -3.35% | 4.29% | -6.34% | 1.28% | -7.93% | 7.39% | -4.24% | -15.22% | 3.69% | 7.48% | -3.49% | -20.87% |
| 2021 | 0.57% | 7.27% | 3.48% | 4.94% | 5.04% | 0.90% | 0.16% | 1.35% | -4.83% | 4.64% | -3.76% | 6.94% | 29.19% |
Benchmark Metrics
Nuveen Real Asset Income and Growth Fund has an annualized alpha of 0.03%, beta of 0.68, and R2 of 0.33 versus S&P 500 Index. Calculated based on daily prices since April 30, 2012.
- This stock participated in 111.66% of S&P 500 Index downside but only 87.07% of its upside - more exposed to losses than it benefited from rallies.
- Beta of 0.68 may look defensive, but with R2 of 0.33 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.33 means the benchmark explains less than half of this stock's behavior - treat beta with caution or consider switching to a more representative benchmark.
- Alpha
- 0.03%
- Beta
- 0.68
- R²
- 0.33
- Upside Capture
- 87.07%
- Downside Capture
- 111.66%
Expense Ratio
JRI has a high expense ratio of 2.09%, indicating above-average management fees.
Return for Risk
Risk / Return Rank
JRI ranks 62 for risk / return — better than 62% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Nuveen Real Asset Income and Growth Fund (JRI) and compare them to S&P 500 Index.
| JRI | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.82 | 2.39 | -1.57 |
Sortino ratioReturn per unit of downside risk | 1.16 | 3.25 | -2.09 |
Omega ratioGain probability vs. loss probability | 1.17 | 1.43 | -0.26 |
Calmar ratioReturn relative to maximum drawdown | 0.92 | 3.11 | -2.19 |
Martin ratioReturn relative to average drawdown | 3.43 | 14.38 | -10.95 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Dividends
Dividend History
Nuveen Real Asset Income and Growth Fund provided a 12.49% dividend yield over the last twelve months, with an annual payout of $1.59 per share. The company has been increasing its dividends for 2 consecutive years.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $1.59 | $1.59 | $1.42 | $1.07 | $1.15 | $1.15 | $1.21 | $1.29 | $1.26 | $1.27 | $1.34 | $1.56 |
Dividend yield | 12.49% | 11.77% | 11.83% | 9.18% | 9.90% | 7.18% | 9.06% | 7.05% | 9.33% | 7.21% | 8.57% | 10.33% |
Monthly Dividends
The table displays the monthly dividend distributions for Nuveen Real Asset Income and Growth Fund. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.13 | $0.13 | $0.13 | $0.13 | $0.13 | $0.00 | $0.67 | ||||||
| 2025 | $0.13 | $0.13 | $0.13 | $0.13 | $0.13 | $0.13 | $0.13 | $0.13 | $0.13 | $0.13 | $0.13 | $0.13 | $1.59 |
| 2024 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | $0.13 | $0.13 | $0.13 | $0.13 | $0.13 | $0.13 | $0.13 | $1.42 |
| 2023 | $0.10 | $0.10 | $0.09 | $0.09 | $0.09 | $0.09 | $0.09 | $0.09 | $0.09 | $0.09 | $0.09 | $0.10 | $1.07 |
| 2022 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | $1.15 |
| 2021 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | $1.15 |
Dividend Yield & Payout
Dividend Yield
Nuveen Real Asset Income and Growth Fund has a dividend yield of 12.49%, which means its dividend payment is significantly above the market average.
Payout Ratio
Nuveen Real Asset Income and Growth Fund has a payout ratio of 111.15%, which is above the market average. This might signify the company's strong earnings or financial health. However, it could also hint at a more mature business phase with potentially slower growth.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Nuveen Real Asset Income and Growth Fund. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Nuveen Real Asset Income and Growth Fund was 60.74%, occurring on Mar 18, 2020. Recovery took 1110 trading sessions.
The current Nuveen Real Asset Income and Growth Fund drawdown is 2.81%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
COVID crash2020 | -60.74%Mar 2020 | 23d | 4y 5mo | 4y 5moFeb 2020 - Aug 2024 |
2016 bear market2016 | -29.68%Jan 2016 | 8mo 26d | 7mo 5d | 1y 3moApr 2015 - Aug 2016 |
Rate-hike selloffLate 2018 | -21.99%Dec 2018 | 1y 4mo | 5mo 17d | 1y 10moAug 2017 - Jun 2019 |
2012 correction2012 | -14.64%Jun 2012 | 1mo 24d | 6mo 15d | 8mo 9dMay 2012 - Jan 2013 |
2013 correction2013 | -14.52%Aug 2013 | 3mo 19d | 4mo 24d | 8mo 13dMay 2013 - Jan 2014 |
Drawdown Indicators
| JRI | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -60.74% | -56.78% | -3.96% |
Max Drawdown (1Y)Largest decline over 1 year | -12.92% | -9.10% | -3.82% |
Max Drawdown (3Y)Largest decline over 3 years | -15.35% | -18.90% | +3.55% |
Max Drawdown (5Y)Largest decline over 5 years | -29.40% | -25.43% | -3.97% |
Max Drawdown (10Y)Largest decline over 10 years | -60.74% | -33.92% | -26.82% |
Current DrawdownCurrent decline from peak | -2.81% | 0.00% | -2.81% |
Average DrawdownAverage peak-to-trough decline | -9.05% | -10.72% | +1.67% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.47% | 1.97% | +1.50% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Nuveen Real Asset Income and Growth Fund over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Nuveen Real Asset Income and Growth Fund is priced in the market compared to other companies in the Asset Management industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for JRI, comparing it with other companies in the Asset Management industry. Currently, JRI has a P/E ratio of 4.7. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for JRI relative to other companies in the Asset Management industry. Currently, JRI has a P/S ratio of 4.1. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for JRI in comparison with other companies in the Asset Management industry. Currently, JRI has a P/B value of 1.0. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with JRI
Add Nuveen Real Asset Income and Growth Fund to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with JRI